Surveilling the threat of ovarian cancer
Currently, ovarian cancer is the fifth most frequent cause of cancer-related deaths for women in Western countries, largely due to its often illusive symptoms and lack of adequate screening methods.
“Participating in research on ovarian cancer has been a rewarding experience. I have learned what it means to be a researcher, what we do in the lab is for the greater good of society,” says Rebeca.
Alongside Dr. Patricia Tonin from McGill University’s Department of Human Genetics, she is investigating genetic abnormalities of ovarian cancer specimens. The objective is to improve upon screening and surveillance methods by investigating the role of genetic events and related cancer susceptible genes that occur in ovarian cancer.
When asked why she ultimately chose Mitacs Globalink, Rebeca explains, “Globalink presents all the best opportunities. Not only am I participating in a field of research of my choosing, but I am also taking part in workshops that teach industry-ready skills, all the while working in top-notch research facilities.”
Rebeca explains her dreams for the future, “I want to keep doing what I love to do most, research. I will be applying to grad school, and after my experience here, I intend on doing so in Canada.”
Mitacs thanks the Government of Canada and the Government of Quebec for their support of the Globalink research internship in this story. Across Canada, the Globalink program also receives support from Alberta Innovates, the Government of British Columbia, the Government of New Brunswick, the Government of Newfoundland and Labrador, the Government of Nova Scotia, the Government of Ontario, the Government of Prince Edward Island, the Government of Saskatchewan, and Research Manitoba.
Do you have a business challenge that could benefit from a research solution? If so, contact Mitacs today to discuss partnership opportunities: BD@mitacs.ca